Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 1, 2026

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles
11:08

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles

Published on: April 8, 2012

Lentiviral vectors.

Marc Giry-Laterrière1, Els Verhoeyen, Patrick Salmon

  • 1Faculty of Medicine, Department of Neurosciences, CMU, Geneva, Switzerland.

Methods in Molecular Biology (Clifton, N.J.)
|May 19, 2011
PubMed
Summary

Lentiviral vectors (LVs) offer safe and stable gene transfer into many cell types, including non-dividing cells. This chapter details LV production and titration protocols for research, diagnosis, and therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SLC1A5 augmentation bypasses NK cell transduction barriers to deliver complex CAR payloads.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same author

Engineering precision oncology: Targeting tumors and immune cells with lentiviral vectors.

Molecular therapy. Oncology·2026
Same author

Engineering Bi-Specific CAR-NK Cells to Restore Antibody-Dependent Cellular Cytotoxicity in Solid Tumors.

Cells·2026
Same author

HLF and hTERT cooperatively enable partial immortalization of human hematopoietic stem and progenitor cells.

Frontiers in bioengineering and biotechnology·2026
Same author

Baboon endogenous retrovirus (ERV) envelope pseudotyped lentiviral vectors outperform human ERV lentivectors for transduction of T, B, NK and HSPCs.

Gene therapy·2026
Same author

IKAROS Gene Regulatory Network Reveal ERG as a Vulnerability in B-cell Acute Lymphoblastic Leukemia.

bioRxiv : the preprint server for biology·2026

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • Virology

Background:

  • Lentiviral vectors (LVs) are advanced tools for stable gene transfer in mammalian cells.
  • Unlike other retroviral vectors, LVs can transduce non-dividing primary cells effectively.
  • HIV-1 derived lentivectors have been optimized for safety and versatility.

Purpose of the Study:

  • To provide standardized protocols for lentiviral vector production and titration.
  • To enhance the reliability and reproducibility of LV-mediated gene transfer in research settings.
  • To discuss the latest advancements in lentiviral vector technology for research, diagnostics, and therapeutics.

Main Methods:

  • Detailed laboratory protocols for lentiviral vector production.
  • Standardized methods for lentiviral vector titration.
  • Guidelines for implementing LV technology in research settings.
  • Review of current lentiviral vector designs and applications.

Main Results:

  • Established protocols facilitate the production and titration of lentiviral vectors.
  • Standardization improves the transposability of results across different laboratories.
  • Optimized lentiviral vectors offer enhanced safety and versatility for gene delivery.

Conclusions:

  • Lentiviral vectors are crucial tools for genetic engineering in research, diagnostics, and therapy.
  • Standardized protocols are essential for reliable and reproducible lentiviral vector applications.
  • Ongoing advancements in lentiviral vector technology continue to expand their therapeutic potential.

More Related Videos

Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System
08:46

Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System

Published on: May 24, 2012

Lentiviral Vector Preparation for Efficient Gene and MicroRNA Modulation of Peritoneal Cavity Tissue-Resident Macrophages In Vivo in Mice
06:33

Lentiviral Vector Preparation for Efficient Gene and MicroRNA Modulation of Peritoneal Cavity Tissue-Resident Macrophages In Vivo in Mice

Published on: February 16, 2024

Related Experiment Videos

Last Updated: Jun 1, 2026

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles
11:08

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles

Published on: April 8, 2012

Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System
08:46

Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System

Published on: May 24, 2012

Lentiviral Vector Preparation for Efficient Gene and MicroRNA Modulation of Peritoneal Cavity Tissue-Resident Macrophages In Vivo in Mice
06:33

Lentiviral Vector Preparation for Efficient Gene and MicroRNA Modulation of Peritoneal Cavity Tissue-Resident Macrophages In Vivo in Mice

Published on: February 16, 2024